Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Label-Free Microscopy Method Enables Faster, Quantitative Detection of Malaria

By LabMedica International staff writers
Posted on 23 Apr 2026

Microscopy of blood smears remains a cornerstone for malaria diagnosis but can be slow, stain-dependent, and operator intensive. More...

With more than 200 million infections and over 600,000 deaths annually, faster and more objective readouts could improve testing workflows and surveillance. Aligning results across laboratories is also challenging when interpretation is subjective. To address this, researchers have introduced a microscopy approach that combines a magnetic field with polarized light to provide quantitative measurements, enabling faster and more objective detection of malaria in blood.

The team, comprising researcher Dickson Mwenda Kinyua of Kirinyaga University in Kenya and Pietro Cicuta with his team at the University of Cambridge, developed a magneto-optical microscopy platform that combines a controlled magnetic field with polarized light to visualize and quantify malaria pigment (hemozoin) in blood. The method is designed to generate objective measurements without the need for staining or chemical treatment and is described in a study in Biomedical Optics Express (2026).

The platform exploits physical properties of hemozoin, which is produced when parasites digest hemoglobin inside red blood cells (RBCs). These crystals are magnetically anisotropic and exhibit optical dichroism, meaning they align in a magnetic field and modulate polarized light in an orientation-dependent manner. Under a polarizing microscope, applying the magnetic field induces measurable intensity and contrast shifts. Ratiometric intensity analysis, which compares image intensity before and after magnetic alignment, combined with threshold-based segmentation, links signal strength to hemozoin concentration and enables quantitative readouts.

Laboratory imaging of blood samples with and without malaria produced a consistent signal that increased linearly with hemozoin content, indicating reliable detection and quantification. The team plans to move from controlled experiments to clinical trials, expand testing across a wider range of patient samples, and compare performance with standard methods. Ongoing work targets simpler, faster operation and integration with image analysis and machine learning to reduce expert dependence and improve consistency. 

“Our method not only makes it possible to see malaria but also allows more precise measurements and the potential to map its location in the sample. This quantitative information could be very useful in laboratories and hospitals, where it could provide a faster, more consistent, and sensitive diagnosis. It could also make it possible to develop automated approaches for diagnosis,” said Dickson Mwenda Kinyua, researcher at Kirinyaga University in Kenya.

“Our method doesn't require expert interpretation and works without needing to stain or chemically treat the sample, making testing more accessible and easier to perform consistently,” said Kinyua. "This could lead to earlier detection, better treatment decisions, and ultimately better health outcomes"

Related Links
Kirinyaga University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Hematology Consumables
Bioblood Devices
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image: Graphical Abstract (Image Credit: Cheng N, Ouellette TW, Skead K, et al. Pre-diagnosis plasma cell-free DNA reveals early signatures of prostate and breast cancer risk up to eight years prior to clinical detection. Cell Genomics (2026). DOI:10.1016/j.xgen.2026.101364)

Blood Test Stratifies Prostate and Breast Cancer Risk Years Before Diagnosis

Cancer is the second leading cause of death globally, and late diagnosis contributes substantially to mortality. Routine screening is available for only a few cancer types, while other early detection... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Collaboration combines cognitive assessment, blood testing, phlebotomy, and MRI to support faster diagnosis across the UK (Image Credt: Adobe Stock)

New UK Collaboration Expands Access to Integrated Alzheimer’s Diagnostic Testing

C2N Diagnostics and Cambridge Cognition have partnered with The Alzheimer’s Trust to create an integrated pathway aimed at supporting earlier and more accurate diagnosis of Alzheimer’s disease and related dementias.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.